Global Western Blotting Market Size, Share and Trends Analysis, By Technology (Instruments and Consumables), By Application (Biomedical and Biochemical Research, Disease Diagnostics, and Agriculture), Forecast (2022-2028)

The global western blotting market is expected to grow at a CAGR of 6.5% during the forecast period(2022-2028). When compared to other immunosorbent assays (ISAs), such as ELISA, the western blotting or immunoblotting technique has a number of advantages. Western blotting is a more advanced technique than ELISA as it allows for the separation of protein mixtures based on charge, size, and conformation. In western blotting, the method of stripping can be used to detect multiple targets, whereas, in ELISA, only one protein can be detected. The size of the target protein can be determined using this technique as gel electrophoresis of proteins aids in the separation of proteins into bands. In addition, by running an internal quantity standard alongside the samples in the gel, the protein of interest can be semi-quantified. The efficiency of traditional western blots is variable. Currently, automation allows for higher throughput screening in western blotting, allowing for more trials and faster experimentation. Western blot automation allows for simultaneous analysis of multiple samples. With automated western blot systems, the only manual task is loading the sample.

However, one of the main disadvantages of the western blotting technique is that it takes longer than ELISA and requires highly skilled lab technicians to perform. Another disadvantage of western blotting is that it necessitates a high level of experimentation in terms of gel concentration, protein isolation, and so on. The major factor driving the market growth is the increasing prevalence of HIV around the world. Other major drivers accelerating the growth of the market is the rapidly expanding applications of western blotting in the field of proteomics, as well as increased efforts and investments in R&D by several pharmaceuticals and biotechnology companies.

However, there are a number of factors that are limiting the growth of the western blotting market, such as the development of alpha technology, which is a highly sensitive homogeneous bead-based platform for biomolecule detection. Alpha technology has several advantages over other technologies such as western blotting, such as the lack of cumbersome wash steps and the ability to detect any molecule of interest, primarily from protein complexes. Alpha method can be used with serum, plasma, cell lysate, and cell supernatant samples. As a result, unlike the multiple changes that are common in the western blotting technique, alpha technology is an all-in-one-well protocol. The introduction of such new technologies is likely to restrain the growth of the global western blotting market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Technology
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, and Danaher Corp., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Western Blotting Market Report by Segment

By Technology

• Instruments
• Consumables

By Application

• Biomedical and Biochemical Research
• Disease Diagnostics
• Agriculture